标题
Dualistic Role of BARD1 in Cancer
作者
关键词
-
出版物
Genes
Volume 8, Issue 12, Pages 375
出版商
MDPI AG
发表日期
2017-12-09
DOI
10.3390/genes8120375
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma
- (2017) Mario Capasso et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Integrative clinical genomics of metastatic cancer
- (2017) Dan R. Robinson et al. NATURE
- BARD1 serum autoantibodies for the detection of lung cancer
- (2017) Maxim Pilyugin et al. PLoS One
- Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma
- (2017) Lee D. McDaniel et al. PLoS Genetics
- Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
- (2017) Fergus J. Couch et al. JAMA Oncology
- BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility
- (2017) Wen Fu et al. EBioMedicine
- Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations
- (2016) Natasha G. Caminsky et al. HUMAN MUTATION
- New concepts on BARD1: Regulator of BRCA pathways and beyond
- (2016) Irmgard Irminger-Finger et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population
- (2016) Ruizhong Zhang et al. International Journal of Medical Sciences
- Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
- (2016) Maxim Pilyugin et al. Oncotarget
- Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
- (2016) Vito Alessandro Lasorsa et al. Oncotarget
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer
- (2016) Ozkan Ozden et al. Scientific Reports
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms
- (2015) MAGDALENA RATAJSKA et al. ONCOLOGY REPORTS
- Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk
- (2014) M. Capasso et al. CANCER RESEARCH
- Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs
- (2014) Maxim Pilyugin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Rare Variants in TP53 and Susceptibility to Neuroblastoma
- (2014) Sharon J. Diskin et al. JNCI-Journal of the National Cancer Institute
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Combinations of genetic data in a study of neuroblastoma risk genotypes
- (2014) Mario Capasso et al. Cancer Genetics
- Identifying Mendelian disease genes with the Variant Effect Scoring Tool
- (2013) Hannah Carter et al. BMC GENOMICS
- Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
- (2013) Mo Li et al. CANCER CELL
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Mechanisms of resistance to therapies targeting BRCA-mutant cancers
- (2013) Christopher J Lord et al. NATURE MEDICINE
- HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
- (2013) Ilaria Lepore et al. PLoS One
- Replication of Neuroblastoma SNP Association at the BARD1 Locus in African-Americans
- (2012) V. Latorre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
- (2012) K. R. Bosse et al. CANCER RESEARCH
- Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
- (2012) Mario Capasso et al. CARCINOGENESIS
- The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population
- (2012) Patricio Gonzalez-Hormazabal et al. MOLECULAR BIOLOGY REPORTS
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- Rare Copy Number Variations in Adults with Tetralogy of Fallot Implicate Novel Risk Gene Pathways
- (2012) Candice K. Silversides et al. PLoS Genetics
- Cancer predisposing BARD1 mutations in breast–ovarian cancer families
- (2011) Magdalena Ratajska et al. BREAST CANCER RESEARCH AND TREATMENT
- Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers
- (2011) A. B. Spurdle et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- BARD1 Expression Predicts Outcome in Colon Cancer
- (2011) Judith C. Sporn et al. CLINICAL CANCER RESEARCH
- BARD1: An independent predictor of survival in non-small cell lung cancer
- (2011) Yong-Qiang Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls
- (2011) Da-Peng Ding et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
- (2011) Lễ B. Nguyễn et al. PLoS Genetics
- Cancer predisposing missense and protein truncatingBARD1mutations in non-BRCA1orBRCA2breast cancer families
- (2010) Sylvia De Brakeleer et al. HUMAN MUTATION
- Negative feedback loop of BRCA1–BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1
- (2010) Eva Dizin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1 Scaffolds Aurora B and BRCA2
- (2009) S. Ryser et al. CANCER RESEARCH
- Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations
- (2009) H. Carter et al. CANCER RESEARCH
- BARD1, a possible biomarker for breast and ovarian cancer
- (2009) Irmgard Irminger-Finger GYNECOLOGIC ONCOLOGY
- Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer
- (2009) Frédéric Guénard et al. JOURNAL OF HUMAN GENETICS
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis
- (2008) Sharon E. Johnatty et al. BREAST CANCER RESEARCH AND TREATMENT
- Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma
- (2008) John M. Maris et al. NEW ENGLAND JOURNAL OF MEDICINE
- The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression
- (2008) R. Shakya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation